Results 231 to 240 of about 921,567 (386)
A case of gastric cancer with polycystic kidney.
Shoichi Tsukayama, Kouzen YAMAMURA
openalex +2 more sources
Herein, polymer nanogels with a reporting interface for albumin are synthesized through reversible addition–fragmentation chain transfer (RAFT) precipitation polymerization of di(ethylene glycol) methyl ether methacrylate and N,N’‐methylenebis(acrylamide) using a poly(2‐methacryloyloxyethyl phosphorylcholine) macro‐RAFT agent, followed by dansyl ...
Yukiya Kitayama+2 more
wiley +1 more source
Epidemiological profile of kidney cancer in Brazil: a multiregional ecological study. [PDF]
Silva CED+5 more
europepmc +1 more source
Photodynamic therapy (PDT) faces clinical challenges due to poor tumor targeting and systemic toxicity. Herein, a biomimetic C3N4‐RP@RBCm nanoplatform is developed via erythrocyte membrane encapsulation, enabling CD47‐mediated immune evasion and EPR‐driven tumor accumulation.
Jiaxiu Liu+9 more
wiley +1 more source
Is early-life obesity associated with kidney cancer in adulthood?-insights from genetic studies. [PDF]
Yang S+5 more
europepmc +1 more source
The von Hippel-Lindau Gene, Kidney Cancer, and Oxygen Sensing
William G. Kaelin
openalex +1 more source
Red Multi‐Resonant Thermally Activated Delayed Fluorescence Emitters as Bioimaging Agents
Multi‐resonant thermally activated delayed fluorescence (MR‐TADF) emitters have attracted strong interest for use in electroluminescent devices due to their high photoluminescence quantum yield and narrowband emission. These properties, along with red emission, are also crucial for bioimaging probes.
Changfeng Si+4 more
wiley +1 more source
Adjuvant pembrolizumab following kidney cancer surgery A novel patient decision aid to facilitate shared decision-making. [PDF]
McAlpine K+9 more
europepmc +1 more source
von Hippel-Lindau Tumor Suppressor Protein and Hypoxia-Inducible Factor in Kidney Cancer
Mindy A. Maynard, Michael Ohh
openalex +1 more source